Leonie M. Weskamm

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity

Christian Meyer zu Natrup, Alina Tscherne, Christine Dahlke et al. · Journal of Clinical Investigation · 2022 · 32 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +12

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

Leonie M. Weskamm, Anahita Fathi, Matthijs P. Raadsen et al. · Cell Reports Medicine · 2022 · 27 citations · Full text

Humoral Response, Immunology, Immunodominance +17

Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens

Leonie M. Weskamm, Christine Dahlke, Marylyn M. Addo · STAR Protocols · 2022 · 18 citations · Full text

Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial

Matthijs P. Raadsen, Christine Dahlke, Anahita Fathi et al. · The Lancet Infectious Diseases · 2024 · 14 citations · Full text

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine

Ivan Odak, Lennart Riemann, Inga Sandrock et al. · EBioMedicine · 2023 · 11 citations · Full text